Patient Guide: Safety and Efficacy Study of Investigational Agents as Monotherapy or in Combination With Pembrolizumab (MK-3475) for the Treatment of Extensive-Stage Small Cell Lung Cancer (ES-SCLC) in Need of Second-Line Therapy (MK-3475-B98/KEYNOTE-B98)

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 48 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT04938817
Status: 🟢 Enrolling Now
Condition: Small Cell Lung Carcinoma
Phase: PHASE1, PHASE2

Where You Can Participate

This study is available at 48 locations across the country.

Top locations include:
  • • Gilbert, Arizona
  • • Atlanta, Georgia
  • • Fort Wayne, Indiana
  • • And 45 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

Safety and Efficacy Study of Investigational Agents as Monotherapy or in Combination With Pembrolizumab (MK-3475) for the Treatment of Extensive-Stage Small Cell Lung Cancer (ES-SCLC) in Need of Second-Line Therapy (MK-3475-B98/KEYNOTE-B98) - Join Clinical Trial NCTNCT04938817

How to Join This Clinical Trial - NCTNCT04938817

Learn how to participate in this PHASE1, PHASE2 trial studying an investigational therapy for Small Cell Lung Carcinoma. This study is currently enrolling participants.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Small Cell Lung Carcinoma. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Small Cell Lung Carcinoma
Treatment Being Tested
Investigational treatment
Study Phase
PHASE1, PHASE2 - Safety and effectiveness study
Enrollment Status
Currently enrolling participants
Study Identifier
NCTNCT04938817 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 48 locations. Find a study site near you:

Clinical Research Site

Gilbert, Arizona 85234 - United States

Status: RECRUITING

Clinical Research Site

Atlanta, Georgia 30342 - United States

Status: COMPLETED

Clinical Research Site

Fort Wayne, Indiana 46845 - United States

Status: COMPLETED

Clinical Research Site

Lexington, Kentucky 40503 - United States

Status: COMPLETED

Clinical Research Site

Lexington, Kentucky 40536 - United States

Status: COMPLETED

Clinical Research Site

Baltimore, Maryland 21237 - United States

Status: COMPLETED

Clinical Research Site

Omaha, Nebraska 68130 - United States

Status: COMPLETED

Clinical Research Site

Omaha, Nebraska 68130 - United States

Status: COMPLETED

Clinical Research Site

Cleveland, Ohio 44195 - United States

Status: COMPLETED

Clinical Research Site

Pittsburgh, Pennsylvania 15232 - United States

Status: COMPLETED

And 38 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE1, PHASE2 clinical trial for Small Cell Lung Carcinoma:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships